ClinConnect ClinConnect Logo
Search / Trial NCT05225467

Development of Ketoacidosis During the Perioperative Period: an Observational Study 'The DKAP Study'

Launched by ACADEMISCH MEDISCH CENTRUM - UNIVERSITEIT VAN AMSTERDAM (AMC-UVA) · Feb 1, 2022

Trial Information

Current as of August 02, 2025

Completed

Keywords

Surgery Ketones

ClinConnect Summary

Study procedures On the first day of admission, all the patients scheduled for cardiac surgery with an on-pump procedure will be asked for a consent for anonymous using of their information. Patients giving permission will be screened for participation in this study, and those fulfil the inclusion/exclusion criteria will be included for further research.

Blood ketone will be measured with StatStrip Glucose/Ketone Meters (Nova biomedical, United Kingdom) using sample leftover from blood gas analysis. No extra blood draw is needed. The levels of ketones will be measured at four time points:
...

Gender

ALL

Eligibility criteria

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria:
  • Inclusion Criteria
  • Aged eighteen years or older
  • Scheduled for open heart surgery
  • Exclusion criteria
  • Diagnosed with type 1 diabetes mellitus or latent auto-immune diabetes in adults
  • Recently used sodium glucose transport co-enzyme 2 (SGLT-2i's) within 2 weeks before surgery)
  • History of recurrent ketoacidosis (two times or more within three months)
  • Emergency surgery
  • (Suspected) pregnancy

About Academisch Medisch Centrum Universiteit Van Amsterdam (Amc Uva)

The Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) is a leading academic medical center in the Netherlands, dedicated to advancing healthcare through innovative research, education, and patient care. Affiliated with the University of Amsterdam, AMC-UvA integrates clinical practice with cutting-edge biomedical research, fostering a multidisciplinary approach to medical challenges. The institution actively engages in clinical trials to enhance treatment options and improve patient outcomes, while promoting collaboration among healthcare professionals, researchers, and academic institutions globally. With a commitment to excellence and a focus on translational medicine, AMC-UvA plays a pivotal role in shaping the future of healthcare.

Locations

Amsterdam Zuidoost, Noord Holland, Netherlands

Patients applied

0 patients applied

Trial Officials

Jeroen Hermanides, dr

Principal Investigator

Amsterdam Univeristy medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials